Screener
Labcorp Holdings LH Unbilled Revenue
Unbilled Revenue at other companies
Other financials
Where this comes from
Reported directly by Labcorp Holdings in its filing.
Tagged under the XBRL concept us-gaap:UnbilledContractsReceivable.
The source filing: Labcorp Holdings’s 8-K, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 6:53 AM EDT
- Accession
- 0000920148-26-000162
FAQ
- What is Labcorp Holdings's unbilled revenue?
- Labcorp Holdings (LH) reported unbilled revenue of $162.4M in Q2 2026.
- How has Labcorp Holdings's unbilled revenue changed year-over-year?
- Labcorp Holdings's unbilled revenue increased by 4.0% year-over-year, from $156.1M to $162.4M.
- What is the long-term trend for Labcorp Holdings's unbilled revenue?
- Over 5 years (2020 to 2025), Labcorp Holdings's unbilled revenue has grown at a -21.8% compound annual growth rate (CAGR), from $536.8M to $156.9M.
- What does unbilled revenue mean?
- This represents revenue that has been earned through the performance of laboratory tests but has not yet been formally invoiced to the payer or patient. It arises due to timing differences between service delivery and the completion of the billing cycle. High levels can indicate operational bottlenecks in the revenue cycle or specific contract terms with large health systems.
Ask your AI about Labcorp Holdings's unbilled revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude